Isla Mackenzie

Academic, Clinical Professor (Teaching and Research) of Cardiovascular Medicine

University of Dundee

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Isla Mackenzie is a Clinical Professor (Teaching and Research) of Cardiovascular Medicine at the University of Dundee, UK. Her research focuses on the cost-effectiveness of diabetes treatments, the comparative effectiveness of hypertension medications, and the application of digital platforms in decentralized clinical trials. Recent publications also address the impact of heart failure therapy post-cancer diagnosis and the influence of antihypertensive dosing based on patient chronotype on cardiovascular outcomes.

Articles (22)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (21)

Madeleine Clout

Professional and Administrative, Trial Portfolio Lead

University of Bristol

UNITED KINGDOM

Isla Mackenzie

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

Cost‐effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension

UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide

Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials

The Digital Platform and Its Emerging Role in Decentralized Clinical Trials

Impact of Post Manufacturing Handling of Protein-Based Biologic Drugs on Product Quality and User Centricity

Use of heart failure medical therapy before and after a cancer diagnosis

Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes

Effect of statin treatment on the risk of cancer in patients with heart failure

Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease

Vascular and inflammatory biomarkers of cardiovascular events in non-steroidal anti-inflammatory drug users

Design, recruitment and baseline characteristics of the LENS trial.

Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea

A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs)

Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME Study)

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART)

A systematic review of methods used to conduct decentralised clinical trials

Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study

Evaluating Diuretics in Normal Care (EVIDENCE)

Factors influencing home blood pressure monitor ownership in a large clinical trial

Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders

A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trials

Collaborators (21)

Madeleine Clout

Jaspal S Taggar

Matthew Sydes

Rebecca Cannings-John

Amy Rogers

Amanda Farrin

Allan Struthers

Jennifer Logue

Saiam Ahmed

Michelle Goonasekera

Alex McConnachie

Alexander Doney

Ghislaine van Thiel

Li Wei

Mary Joan Macleod

Sten Hanke

Marie Wahlgren

Giorgia De Paoli

Thomas MacDonald

Wallis Lau

Mira Zuidgeest

Make your next move.